Release Date: 19/05/10 16:10 Summary: Ceasing to be a substantial holder Price Sensitive: No Download Document 81.24KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%